APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease
Open accessAbstract
This study aimed to evaluate the impact of APOE4 homozygosity on Alzheimer's disease (AD) by examining its clinical, pathological and biomarker changes to see whether APOE4 homozygotes constitute a distinct, genetically determined form of AD. Data from the National Alzheimer's Coordinating Center and five large cohorts with AD biomarkers were analyzed. The analysis included 3,297 individuals for the pathological study and 10,039 for the clinical study. Findings revealed that almost all APOE4 homozygotes exhibited AD pathology and had significantly higher levels of AD biomarkers from age 55 compared to APOE3 homozygotes. By age 65, nearly all had abnormal amyloid levels in cerebrospinal fluid, and 75% had positive amyloid scans, with the prevalence of these markers increasing with age, indicating near-full penetrance of AD biology in APOE4 homozygotes. The age of symptom onset was earlier in APOE4 homozygotes at 65.1, with a narrower 95% prediction interval than APOE3 homozygotes. The predictability of symptom onset and the sequence of biomarker changes in APOE4 homozygotes mirrored those in autosomal dominant AD and Down syndrome. However, in the dementia stage, there were no differences in amyloid or tau positron emission tomography across haplotypes, despite earlier clinical and biomarker changes. The study concludes that APOE4 homozygotes represent a genetic form of AD, suggesting the need for individualized prevention strategies, clinical trials and treatments.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Allelic variation in the APOE gene is a strong genetic risk factor for AD.
“APOE is a lipoprotein involved in the transport of cholesterol and phospholipids between cells, and allelic variation in the APOE gene is a strong genetic risk factor for AD [16, 44].”
From Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome–Alzheimer’s disease (2025) · cites this paper as [16]
The isoform variation of APOE is associated with an increased risk of developing AD in the general population.
“The isoform variation of the protein is associated with an increased risk of developing AD in the general population [11, 16, 44].”
From Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome–Alzheimer’s disease (2025) · cites this paper as [16]
APOE4 increases the odds ratio of developing Alzheimer's Disease.
“APOE4 is the strongest genetic risk factor for AD not only increasing the odds ratio of developing the disease but also lowering the age of onset in a dose-dependent fashion.17, 18”
From ApoE is Secreted as a Lipid Nanoparticle by Mammalian Cells: Implications for Alzheimer’s Disease Pathogenesis (2025) · cites this paper as [18]
APOE4 is the strongest genetic risk factor for Alzheimer's Disease.
“APOE4 is the strongest genetic risk factor for AD not only increasing the odds ratio of developing the disease but also lowering the age of onset in a dose-dependent fashion.17, 18”
From ApoE is Secreted as a Lipid Nanoparticle by Mammalian Cells: Implications for Alzheimer’s Disease Pathogenesis (2025) · cites this paper as [18]
APOE4 lowers the age of onset of Alzheimer's Disease in a dose-dependent fashion.
“APOE4 is the strongest genetic risk factor for AD not only increasing the odds ratio of developing the disease but also lowering the age of onset in a dose-dependent fashion.17, 18”
From ApoE is Secreted as a Lipid Nanoparticle by Mammalian Cells: Implications for Alzheimer’s Disease Pathogenesis (2025) · cites this paper as [18]
APOEε4 homozygosity may approach 100% penetrance for Aβ deposition in the brain.
“Although APOEε4 homozygosity may approach 100% penetrance for Aβ deposition in the brain16, even for white or East Asian people, being homozygous for APOEε4 is not synonymous with developing AD dementia”
From Multifaceted roles of APOE in Alzheimer disease (2024) · cites this paper as [16]
APOE is a lipoprotein involved in the transport of cholesterol and phospholipids between cells.
“APOE is a lipoprotein involved in the transport of cholesterol and phospholipids between cells, and allelic variation in the APOE gene is a strong genetic risk factor for AD [16, 44].”
From Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome–Alzheimer’s disease (2025) · cites this paper as [16]
The cited paper’s Results discuss APOE genotype and Alzheimer’s disease neuropathology, but the passages do not describe APOE as a lipoprotein or say that it transports cholesterol and phospholipids between cells. Searches for those terms and for apolipoprotein E’s role in lipid transport found no passage addressing the quoted claim. (LLM, conf=0.74)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537 · see citing works
Self-citationThe Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882 · see citing works
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814 · see citing works
Self-citationMontine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,992 · see citing works
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01024-z · Cited by 2,498 · see citing works
Self-citationPrevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis
Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA · doi:10.1001/jama.2015.4668 · Cited by 1,610 · see citing works
Self-citationLaMontagne, P. J., Benzinger, T. L., Morris, J. C., Keefe, S., Hornbeck, R., Xiong, C., Grant, E., Hassenstab, J., Moulder, K., Vlassenko, A. G., et al. (2019) · medRxiv · doi:10.1101/2019.12.13.19014902 · Cited by 779 · see citing works
The A4 Study: Stopping AD Before Symptoms Begin?
Sperling, R. A., Rentz, D. M., Johnson, K. A., Karlawish, J. H., Donohue, M., Salmon, D. P., & Aisen, P. S. S. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007941 · Cited by 756 · see citing works
Self-citationAPOE and Alzheimer disease: a major gene with semi-dominant inheritance
Genin, E., Hannequin, D., Wallon, D., Sleegers, K., Hiltunen, M., Combarros, O., Bullido, M. J., Engelborghs, S., De Deyn, P., Berr, C., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.52 · Cited by 714 · see citing works
A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward
Belloy, M. E., Napolioni, V., & Greicius, M. D. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.056 · Cited by 570 · see citing works
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
Frisoni, G. B., Altomare, D., Thal, D. R., Ribaldi, F., van der Kant, R., Ossenkoppele, R., Blennow, K., Cummings, J., van Duijn, C., Nilsson, P. M., et al. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00533-w · Cited by 513 · see citing works
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Morris, J. C., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.10.006 · Cited by 497 · see citing works
Reiman, E. M., Arboleda-Velasquez, J. F., Quiroz, Y. T., Huentelman, M. J., Beach, T. G., Caselli, R. J., Chen, Y., Su, Y., Myers, A. J., Hardy, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14279-8 · Cited by 473 · see citing works
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
(2012) · New England Journal of Medicine · doi:10.1056/nejmx120056 · Cited by 382 · see citing works
Alzheimer's disease associated with Down syndrome: a genetic form of dementia
Fortea, J., Zaman, S. H., Hartley, S., Rafii, M. S., Head, E., & Carmona-Iragui, M. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00245-3 · Cited by 357 · see citing works
Self-citationThe National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database.
Beekly, D. L., Ramos, E. M., van Belle, G., Deitrich, W. D., Clark, A. D., Jacka, M. E., & Kukull, W. A. (2004) · PubMed · Cited by 345 · see citing works
Fortea, J., Vilaplana, E., Carmona-Iragui, M., Benejam, B., Videla, L., Barroeta, I., Fernández, S., Altuna, M., Pegueroles, J., Montal, V., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30689-9 · Cited by 340 · see citing works
Self-citation<i>APOE</i> Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry
Belloy, M. E., Andrews, S. J., Le Guen, Y., Cuccaro, M., Farrer, L. A., Napolioni, V., & Greicius, M. D. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.3599 · Cited by 320 · see citing works
La Joie, R., Ayakta, N., Seeley, W. W., Borys, E., Boxer, A. L., DeCarli, C., Doré, V., Grinberg, L. T., Huang, E., Hwang, J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.09.001 · Cited by 317 · see citing works
van der Lee, S. J., Wolters, F. J., Ikram, M. K., Albert Hofman, D., Ikram, M. A., Amin, N., & van Duijn, C. M. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30053-x · Cited by 297 · see citing works
Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome
Iulita, M. F., Garzón Chavez, D., Klitgaard Christensen, M., Valle Tamayo, N., Plana-Ripoll, O., Rasmussen, S. A., Roqué Figuls, M., Alcolea, D., Videla, L., Barroeta, I., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.12910 · Cited by 195 · see citing works
Self-citationMolinuevo, J. L., Gramunt, N., Gispert, J. D., Fauria, K., Esteller, M., Minguillón, C., Sánchez‐Benavides, G., Huesa, G., Morán, S., Dal‐Ré, R., et al. (2016) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2016.02.003 · Cited by 177 · see citing works
Self-citationMulti-method investigation of factors influencing amyloid onset and impairment in three cohorts
Betthauser, T. J., Bilgel, M., Koscik, R. L., Jedynak, B., An, Y., Kellett, K. A., Moghekar, A., Jonaitis, E. M., Stone, C. K., Engelman, C. D., et al. (2022) · Brain · doi:10.1093/brain/awac213 · Cited by 130 · see citing works
Self-citationPrevalence of cerebral amyloid pathology in persons without dementia: A meta-analysis
Jansen, W., Ossenkoppele, R., Knol, D., Tijms, B., Scheltens, P., Fr, V., Visser, P. J., Amyloid Biomarker Study Group, Aalten, P., Aarsland, D., et al. (2015) · Archive ouverte UNIGE (University of Geneva) · Cited by 94 · see citing works
Self-citationTherriault, J., Pascoal, T. A., Benedet, A. L., Tissot, C., Savard, M., Chamoun, M., Lussier, F., Kang, M. S., Berzgin, G., Wang, T., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011416 · Cited by 91 · see citing works
Mehta, R. I., & Schneider, J. A. (2021) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000912 · Cited by 84 · see citing works
Sadikki, H., Fayossé, A., Cognat, E., Sabia, S., Engelborghs, S., Wallon, D., Alexopoulos, P., Blennow, K., Zetterberg, H., Parnetti, L., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1003289 · Cited by 79 · see citing works
Jack, C. R., Therneau, T. M., Lundt, E. S., Wiste, H. J., Mielke, M. M., Knopman, D. S., Graff‐Radford, J., Lowe, V. J., Vemuri, P., Schwarz, C. G., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac017 · Cited by 55 · see citing works
Ghisays, V., Goradia, D. D., Protas, H. D., Bauer, R. J., III, Devadas, V., Tariot, P. N., Lowe, V. J., Knopman, D. S., Petersen, R. C., Jack, C. R., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.08.195 · Cited by 35 · see citing works
Snellman, A., Ekblad, L. L., Tuisku, J., Koivumäki, M., Ashton, N. J., Lantero‐Rodriguez, J., Karikari, T. K., Helin, S., Bucci, M., Löyttyniemi, E., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01209-6 · Cited by 30 · see citing works
Lessons from Down syndrome and autosomal dominant Alzheimer's disease
Fortea, J., Quiroz, Y. T., & Ryan, N. S. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00437-9 · Cited by 10 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [29]Johnson SC The Wisconsin Registry for Alzheimer’s Prevention: a review of findings and current directions. Alzheimer’s Dement.: Diagnosis, Assess. Dis. Monit. 10, 130– 142 (2018). PMC5755749 29322089
Cited by
Sorted by citations
Multifaceted roles of APOE in Alzheimer disease
Jackson, R. J., Hyman, B. T., & Serrano-Pozo, A. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00988-2 · Cited by 193 · see citing works
Alzheimer’s Disease: Exploring the Landscape of Cognitive Decline
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00339 · Cited by 170 · see citing works
Lifetime risk and projected burden of dementia
Fang, M., Hu, J., Weiss, J., Knopman, D. S., Albert, M., Windham, B. G., Walker, K. A., Sharrett, A. R., Gottesman, R. F., Lutsey, P. L., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03340-9 · Cited by 153 · see citing works
The Glutamate/ GABA ‐Glutamine Cycle: Insights, Updates, and Advances
Andersen, J. V. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70029 · Cited by 156 · see citing works
Ossenkoppele, R., Coomans, E. M., Apostolova, L. G., Baker, S. L., Barthel, H., Beach, T. G., Benzinger, T. L. S., Betthauser, T. J., Bischof, G. N., Bottlaender, M., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02000-6 · Cited by 56 · see citing works
Self-citationLiu, Y., Gu, X., Li, Y., Wang, F., Vyas, C. M., Peng, C., Dong, D., Li, Y., Zhang, Y., Zhang, Y., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03891-5 · Cited by 54 · see citing works
Insights into the use of biomarkers in clinical trials in Alzheimer's disease
Pascoal, T. A., Aguzzoli, C. S., Lussier, F. Z., Crivelli, L., Suemoto, C. K., Fortea, J., Rosa‐Neto, P., Zimmer, E. R., Ferreira, P. C. L., & Bellaver, B. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105322 · Cited by 55 · see citing works
Self-citationAlzheimer’s disease pathogenesis: standing at the crossroad of lipid metabolism and immune response
Wang, Z., Zhang, L., & Qin, C. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00857-6 · Cited by 54 · see citing works
Schwartz, S. S., Herman, M. E., Tun, M. T. H., Barone, E., & Butterfield, D. A. (2024) · BMC Medicine · doi:10.1186/s12916-024-03763-8 · Cited by 47 · see citing works
Recent advances in therapeutic probiotics: insights from human trials
Cho, M.-Y., Eom, J.-H., Choi, E.-M., Yang, S., Lee, D., Kim, Y.-Y., Kim, H.-S., & Hwang, I. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00240-24 · Cited by 52 · see citing works
The impact of rare genetic variants on Alzheimer disease
Deyn, L. D., & Sleegers, K. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01062-1 · Cited by 43 · see citing works
Ding, J., Zhao, C., Hao, X., & Jiao, H. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70709 · Cited by 42 · see citing works
Hey, J. A., Abushakra, S. R., Blennow, K., Reiman, E. M., Hort, J., Prins, N. D., Sheardová, K., Kesslak, P. J., Shen, L. Z., Zhu, X., et al. (2024) · Drugs · doi:10.1007/s40265-024-02067-8 · Cited by 43 · see citing works
Bougea, A. M., & Gourzis, P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164661 · Cited by 43 · see citing works
Padovani, A., Galli, A., Bazzoli, E., Tolassi, C., Caratozzolo, S., Gumina, B., Benussi, A., Libri, I., Outeiro, T. F., & Pilotto, A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14556 · Cited by 37 · see citing works
Organ-specific proteomic aging clocks predict disease and longevity across diverse populations
Wang, Y., Xiao, S., Liu, B., Jiang, R., Liu, Y., Hang, Y., Chen, L., Chen, R., Vitiello, M. V., Bennett, D., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-01016-8 · Cited by 44 · see citing works
Alzheimer's Disease Sequencing Project release 4 whole genome sequencing dataset
Leung, Y. Y., Lee, W., Kuzma, A. B., Nicaretta, H. I., Valladares, O., Gangadharan, P., Qu, L., Zhao, Y., Ren, Y., Cheng, P., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70237 · Cited by 38 · see citing works
The Role of Genetic, Environmental, and Dietary Factors in Alzheimer’s Disease: A Narrative Review
Mertaş, B., & Boşgelmez, İ. İ. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031222 · Cited by 35 · see citing works
Neural Metabolic Networks: Key Elements of Healthy Brain Function
Madrer, N., Perera, N. D., Uccelli, N. A., Abbondanza, A., Andersen, J. V., Carsana, E. V., Demmings, M. D., Fernandez, R. F., de Fragas, M. G., Gbadamosi, I., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70084 · Cited by 35 · see citing works
APOE4 reshapes the lipid droplet proteome and modulates microglial inflammatory responses
Friday, C. M., Stephens, I. O., Smith, C. T., Lee, S., Satish, D., Devanney, N. A., Cohen, S., Morganti, J. M., Gordon, S. M., & Johnson, L. A. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106983 · Cited by 33 · see citing works
Whitman, E. T., Elliott, M. L., Knodt, A. R., Abraham, W. C., Anderson, T. J., Cutfield, N. J., Hogan, S., Ireland, D., Melzer, T. R., Ramrakha, S., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00897-z · Cited by 37 · see citing works
Aisen, P. S. S., Bateman, R. J., Crowther, D. C., Cummings, J., Dwyer, J. R., Iwatsubo, T., Kosco‐Vilbois, M. H., McDade, E., Mohs, R. C., Scheltens, P., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14342 · Cited by 33 · see citing works
Self-citationKantor, B., O’Donovan, B., & Chiba‐Falek, O. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102635 · Cited by 36 · see citing works
Heterogeneity of Astrocyte Reactivity
Clayton, B. L. L., & Liddelow, S. A. (2025) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-112723-031738 · Cited by 30 · see citing works
Tran, K. M., Kwang, N. E., Butler, C. A., Gomez-Arboledas, A., Kawauchi, S., Mar, C., Chao, D., Barahona, R. A., Da Cunha, C., Tsourmas, K. I., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00793-x · Cited by 28 · see citing works
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-β
Cicognola, C., Salvadó, G., Smith, R. A., Palmqvist, S., Stomrud, E., Betthauser, T. J., Johnson, S. C., Janelidze, S., Mattsson, N., Hansson, O., et al. (2025) · Brain · doi:10.1093/brain/awaf016 · Cited by 29 · see citing works
Self-citationAPOE4 , Blood Neurodegenerative Biomarkers, and Cognitive Decline in Community-Dwelling Older Adults
Ng, T. K. S., Beck, T. L., Boyle, P. A., Dhana, K., Desai, P., Evans, D. A., & Rajan, K. B. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.8903 · Cited by 29 · see citing works
Ketone body metabolism and the NLRP3 inflammasome in Alzheimer's disease
Shippy, D. C., Evered, A. H., & Ulland, T. K. (2024) · Immunological Reviews · doi:10.1111/imr.13365 · Cited by 29 · see citing works
Contador, I., Buch-Vicente, B., del Ser, T., Velasco, S. L., Villarejo‐Galende, A., Benito‐León, J., & Bermejo‐Pareja, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144100 · Cited by 30 · see citing works
Advancements and challenges in mouse models of Alzheimer’s disease
Qian, Z., Li, Y., & Ye, K. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.10.010 · Cited by 28 · see citing works
Recent advances in neuroimaging of Alzheimer's disease and related dementias
Ottoy, J., Owsicki, N., Bilgel, M., Binette, A. P., Salvadó, G., Kang, M. S., Cash, D. M., Ewers, M., Joie, R. L., Wisse, L. E. M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70648 · Cited by 27 · see citing works
Modeling Alzheimer’s disease using human cell derived brain organoids and 3D models
Fernandes, S., Revanna, J. S., Pratt, J. M., Hayes, N., Marchetto, M. C., & Gage, F. H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1434945 · Cited by 29 · see citing works
Abushakra, S. R., Porsteinsson, A. P., Sabbagh, M., Watson, D., Power, A., Liang, E., MacSweeney, E., Boada, M., Flint, S., McLaine, R., et al. (2024) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12498 · Cited by 27 · see citing works
Chen, J., Zhao, S., Zhou, Y., Wang, L., Chen, Q., & Zheng, K. (2025) · BioScience Trends · doi:10.5582/bst.2025.01148 · Cited by 27 · see citing works
Kalkman, H. O., & Smigielski, L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04989-0 · Cited by 29 · see citing works
Sex Differences in Apolipoprotein E and Alzheimer Disease Pathology Across Ancestries
Xu, X., Kwon, J., Yan, R., Apio, C., Song, S. C., Heo, G., Yang, Q., Timsina, J., Liu, M., Budde, J., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.0562 · Cited by 26 · see citing works
Self-citationA manifesto for Alzheimer’s disease drug discovery in the era of disease-modifying therapies
Hering, H., Bussière, T., Liu, C., Glajch, K. E., Weihofen, A., Grogan, J. L., & Walsh, D. M. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00872-7 · Cited by 26 · see citing works
Budny, V., Ruminot, I., Wybitul, M., Treyer, V., Barros, L. F., & Tackenberg, C. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03550-w · Cited by 25 · see citing works
Abushakra, S. R., Power, A., Watson, D., Porsteinsson, A. P., Sabbagh, M., MacSweeney, E., Cohen, S., Boada, M., Doraiswamy, P. M., Liang, E., et al. (2025) · Drugs · doi:10.1007/s40265-025-02250-5 · Cited by 25 · see citing works
Feringa, F. M., Hertog, S. K.-D., Wang, L. Y., Derks, R. J. E., Kruijff, I. D., Erlebach, L., Heijneman, J., Miramontes, R., Pömpner, N., Blomberg, N., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.01.601474 · Cited by 21 · see citing works
Mendes, A. J., Ribaldi, F., Pievani, M., Boccalini, C., Garibotto, V., Frisoni, G. B., & Initiative, A. D. N. (2025) · Neurology · doi:10.1212/wnl.0000000000213675 · Cited by 20 · see citing works
Richardson, T. E., Walker, J. M., Farrell, K. W., Oliveira, T. G., White, C. L., & Crary, J. F. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02943-x · Cited by 21 · see citing works
APOE4 homozygosity is a new genetic form of Alzheimer’s disease
Xu, Q., Liang, Z., & Huang, Y. (2024) · Nature Medicine · doi:10.1038/s41591-024-02923-w · Cited by 18 · see citing works
Dittrich, A., Blennow, K., Tan, K., Benedet, A. L., Skoog, I., Höglund, K., Ashton, N. J., Zetterberg, H., & Kern, S. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.14610 · Cited by 18 · see citing works
Zhang, W.-X., Yang, Y.-L., Yu, J.-X., Jia, L.-J., & Huang, H.-C. (2025) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2025.152335 · Cited by 17 · see citing works
Bumber, J. R., Rački, V., Mežnarić, S., Pelčić, G., & Mršić‐Pelčić, J. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176047 · Cited by 17 · see citing works
Apolipoprotein E and Alzheimer’s Disease in Italian Population: Systematic Review and Meta-Analysis
Abrego-Guandique, D. M., Saraceno, G. F., Cannataro, R., de Burnside, M. M., Caroleo, M. C., & Cione, E. (2024) · Brain Sciences · doi:10.3390/brainsci14090908 · Cited by 17 · see citing works
Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders
Niazi, S. K., Mariam, Z., & Magoola, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126683 · Cited by 16 · see citing works
Vanderlip, C. R., & Stark, C. E. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70355 · Cited by 15 · see citing works
Benussi, A., Agosta, F., Alfano, A. R., Antico, A., Bellelli, G., Bonanni, L., Bottini, G., Bozzali, M., Brignoli, O., Bruno, G., et al. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08576-y · Cited by 15 · see citing works
Serrano‐Pozo, A., Escott‐Price, V., Grinberg, L. T., Pascoal, T. A., Suárez‐Calvet, M., Dubois, B., & Sperling, R. A. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00198-4 · Cited by 18 · see citing works
Self-citationResistance and resilience to Alzheimer's disease in Down syndrome
Boyle, R. T., Koops, E. A., Ances, B. M., Andrews, E. J., Arenaza‐Urquijo, E. M., Bejanin, A., Brickman, A. M., Buckley, R. F., Clas, G. S., Costello, E., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70151 · Cited by 15 · see citing works
Self-citationChen, X., Xu, H., Yu, S., Hu, W., Zhang, Z., Wang, X., Yuan, Y., Wang, M., Chen, L., Lin, X., et al. (2025) · Biology · doi:10.3390/biology14060651 · Cited by 17 · see citing works
Longitudinal trajectory of plasma p-tau217 in cognitively unimpaired subjects
Martínez‐Dubarbie, F., Guerra-Ruiz, A. R., López‐García, S., Lage, C., Fernández‐Matarrubia, M., Pozueta‐Cantudo, A., García‐Martínez, M., Corrales‐Pardo, A., Bravo, M., López‐Hoyos, M., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01642-1 · Cited by 18 · see citing works
Impact of APOE , Klotho, and sex on cognitive decline with aging
Shibata, K., Chen, C., Tai, X. Y., Manohar, S., & Masud Husain, B. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2416042122 · Cited by 17 · see citing works
Lagarde, J., Maiti, P., Schonhaut, D. R., Blazhenets, G., Zhang, J., Eloyan, A., Thangarajah, M., Taurone, A., Allen, I. E., Soleimani‐Meigooni, D. N., et al. (2025) · Annals of Neurology · doi:10.1002/ana.27233 · Cited by 14 · see citing works
Models and mechanisms of post-stroke dementia and cognitive impairment
Khan, R., Devlin, P. J., Urayama, A., & Ritzel, R. M. (2025) · Frontiers in Stroke · doi:10.3389/fstro.2025.1563924 · Cited by 14 · see citing works
Montoliu‐Gaya, L., Bian, S., Dammer, E. B., Alcolea, D. A., Sauer, M., Martá-Ariza, M., Ashton, N. J., Belbin, O., Fuchs, J., Watson, C. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61054-z · Cited by 14 · see citing works
Self-citationHerpesviruses, antiviral treatment, and the risk of dementia – systematic review and meta-analysis
Drinkall, N. J., Siersma, V., Lathe, R., Waldemar, G., & Janbek, J. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01838-z · Cited by 14 · see citing works
Oriá, R. B., Smith, C. J., Ashford, J. W., Vitek, M. P., & Guerrant, R. L. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240888 · Cited by 14 · see citing works
Exosomal mRNA Signatures as Predictive Biomarkers for Risk and Age of Onset in Alzheimer’s Disease
Bolívar, D. A., Mosquera-Heredia, M. I., Vidal, O. M., Barceló, E., Allegri, R., Morales, L. C., Silvera-Redondo, C. A., Arcos‐Burgos, M., Garavito, P., & Velez, J. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212293 · Cited by 14 · see citing works
Synergistic reduction in interfacial flexibility of TREM2 R47H and ApoE4 may underlie AD pathology
Lietzke, E. E., Saeb, D., Aldrich, E. C., Bruce, K. D., & Sprenger, K. G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70120 · Cited by 14 · see citing works
ApoE-calypse tau: ApoE–tau synergy in Alzheimer’s disease
Lennol, M. P., Bordier, C., Kamelher, L., Ulrich, J. D., Holtzman, D. M., & Gratuze, M. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250965 · Cited by 14 · see citing works
Dysregulation of Immune Mediators and Synaptic Plasticity in Central Nervous System Disorders
Imbriani, P., D’Ambra, C., Mori, R. D., Ionta, M., Renna, A., & Bonsi, P. (2026) · Cells · doi:10.3390/cells15020201 · Cited by 15 · see citing works
Lipids and α-Synuclein: adding further variables to the equation
Schepers, J., Löser, T., & Behl, C. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1455817 · Cited by 13 · see citing works
MacMullen, C., Sharma, N., & Davis, R. L. (2024) · Brain · doi:10.1093/brain/awae364 · Cited by 13 · see citing works
Suppressing APOE4-induced neural pathologies by targeting the VHL–HIF axis
Jiang, W. I., Cao, Y., Xue, Y., Ji, Y., Winer, B. Y., Chandra, R., Zhang, X. F., Zhang, M., Singhal, N. S., Pierce-Shimomura, J. T., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2417515122 · Cited by 13 · see citing works
Sex-related differences in genetically determined Alzheimer’s disease
Soriano, L. D. H., Wagemann, O., Bejanin, A., Levin, J., & Fortea, J. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1522434 · Cited by 13 · see citing works
Self-citationMicroglial clearance of Alzheimer's amyloid-beta obstructed by nanoplastics
Wang, Y., Huang, G., Liang, X., Andrikopoulos, N., Tang, H., Ding, F., Ke, P. C., & Li, Y. (2025) · Environmental Science Nano · doi:10.1039/d5en00291e · Cited by 13 · see citing works
Lipid profiling reveals unsaturated lipid reduction in women with Alzheimer's disease
Wretlind, A., Xu, J., Chen, W., Velayudhan, L., Ashton, N. J., Zetterberg, H., Proitsi, P., & Legido‐Quigley, C. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70512 · Cited by 13 · see citing works
Borràs, C., Canyelles, M., Santos, D., Rotllán, N., Núñez, E., Vázquez, J., Maspoch, D., Cano‐Sarabia, M., Zhao, Q., Carmona‐Iragui, M., et al. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100865 · Cited by 12 · see citing works
Self-citationEffective in vivo RNA base editing via engineered cytidine deaminase APOBECs fused with PUF proteins
Han, W., Yuan, B., Fan, X., Li, W., Yuan, Y., Zhang, Y., Wang, S., Shan, S., Hafner, M., Wang, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64748-6 · Cited by 12 · see citing works
Rosenberg, A., Solomon, A., Bonnard, A., Daniilidou, M., Hagman, G., Hall, A., Matton, A., Öhlund‐Wistbacka, U., Westman, E., & Kivipelto, M. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100476 · Cited by 12 · see citing works
Hey, J. A., Yu, Y., Abushakra, S. R., Schaefer, J. F., Power, A., Kesslak, P. J., & Tolar, M. (2024) · Drugs · doi:10.1007/s40265-024-02068-7 · Cited by 12 · see citing works
Challenges to identifying risk versus protective factors in Alzheimer’s disease
Pappalettera, C., Carrarini, C., Cappa, S. F., Caraglia, N., Cotelli, M., Marra, C., Perani, D., Redolfi, A., Spadin, P., Tagliavini, F., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03158-5 · Cited by 12 · see citing works
The Risk of Alzheimer Disease in APOE4 Homozygotes
Reiman, E. M., Ghisays, V., & Langbaum, J. B. S. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.0639 · Cited by 14 · see citing works
Cáceres-Palomo, L., Sánchez‐Mejías, E., Trujillo‐Estrada, L., Pérez-Moreno, J. J., Lopez-Oliva, E., Lim, T. E., DeFlitch, L., Chang, S. H., Kampman, L., Corces, M. R., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03607-z · Cited by 11 · see citing works
Five tenets for advancing evidence-based precision medicine
Coral, D., Sargent, J. L., Carrasco-Zanini, J., Coral, L., Deutsch, A. J., Udler, M. S., Giordano, G. N., Pare, G. P., Pearson, E. R., van Smeden, M., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04309-6 · Cited by 12 · see citing works
An interpretable deep learning framework identifies proteomic drivers of Alzheimer’s disease
Panizza, E., & Cerione, R. A. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1379984 · Cited by 11 · see citing works
Crivelli, S. M., Gaifullina, A., & Chatton, J. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1483708 · Cited by 11 · see citing works
Seddon, A. R., MacArthur, C. P., Hampton, M. B., & Stevens, A. J. (2024) · Redox Report · doi:10.1080/13510002.2024.2428152 · Cited by 11 · see citing works
Shvetcov, A., Thomson, S., Cho, A., Wilkins, H., Reed, J. H., Swerdlow, R. H., Brown, D. A., Initiative, T. A. D. N., & Finney, C. A. (2024) · Aging Cell · doi:10.1111/acel.14439 · Cited by 11 · see citing works
Tau biomarkers for neurodegenerative diseases: Current state and perspectives
Vacchi, E., Ruíz‐Barrio, I., & Melli, G. (2025) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2025.107772 · Cited by 11 · see citing works
Giorgio, J., Jonson, C., Wang, Y., Yokoyama, J. S., Wang, J., Jagust, W. J., & Initiative, O. B. O. T. A. D. N. (2025) · Nature Communications · doi:10.1038/s41467-025-60370-8 · Cited by 12 · see citing works
Pan, Y., Chu, C., Wang, Y., Wang, Y., Ji, G., Masters, C. L., Goudey, B., & Jin, L. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102834 · Cited by 10 · see citing works
Min, J.-H., Sarlus, H., & Harris, R. A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1467333 · Cited by 11 · see citing works
Polygenic score integrating neurodegenerative and vascular risk informs dementia risk stratification
D’Aoust, T., Clocchiatti‐Tuozzo, S., Rivier, C. A., Mishra, A., Hachiya, T., Grenier‐Boley, B., Soumaré, A., Duperron, M., Grand, Q. L., Bouteloup, V., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70014 · Cited by 10 · see citing works
Hypothalamic volume, sleep, and APOE genotype in cognitively healthy adults
Laurell, A. A. S., Mak, E., Dounavi, M., Underwood, B. R., Dauvilliers, Y. A., Dudas, R. B., Marguet, O. E., Ritchie, C. W., Koychev, I. G., LAWLOR, B. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70244 · Cited by 10 · see citing works
Self-citationCOVID-19 and Cognitive Change in a Community-Based Cohort
Demmer, R. T., Cornelius, T. M., Kraal, A. Z., Pike, J. R., Sun, Y., Balte, P., Wu, C., Allen, N. B., Cushman, M., Suchy‐Dicey, A. M., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.18648 · Cited by 11 · see citing works
Fischer, L., Molloy, E. N., Binette, A. P., Vockert, N., Marquardt, J., Pilar, A. P., Kreissl, M. C., Remz, J., Tremblay‐Mercier, J., Poirier, J., et al. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1408-24.2024 · Cited by 10 · see citing works
Farrell, C., Buhidma, Y., Mumford, P., Heywood, W. E., Hällqvist, J., Flores-Aguilar, L., Andrews, E. J., Rahimzadah, N., Taso, O. S., Doran, E., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02889-0 · Cited by 9 · see citing works
“APOE is a lipoprotein involved in the transport of cholesterol and phospholipids between cells, and allelic variation in the APOE gene is a strong genetic risk factor for AD [16, 44].”
Ren, L., Hu, F., Walsh, S., Jin, X., Hu, Y., Li, S., Jiang, Y., Yu, M., Wu, Y., Zang, G. Y., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70090 · Cited by 12 · see citing works
Thedim, M., Hu, J., Maher, M., Wiener-Kronish, J. P., Saxena, R., & Vacas, S. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.05.014 · Cited by 9 · see citing works
Ding, J., Sun, B., Gao, Y., Gu, C., Zhang, J., Wang, L., Zheng, J., Xia, B., & Qi, X. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70536 · Cited by 8 · see citing works
Effects of obesogenic diet and 17β-estradiol in female mice with APOE 3/3, 3/4, and 4/4 genotypes
Christensen, A., McGill, C. J., Qian, W., & Pike, C. J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1415072 · Cited by 7 · see citing works
Karan, K. R., Andrzejewski, S., Stiles, K. M., Hackett, N. R., & Crystal, R. G. (2024) · Human Gene Therapy · doi:10.1089/hum.2024.112 · Cited by 8 · see citing works
Johnson, C. N., Lysaker, C. R., McCoin, C. S., Evans, M. R., Thyfault, J. P., Wilkins, H., Morris, J. K., & Geiger, P. C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1486762 · Cited by 6 · see citing works
Regulation of adult neurogenesis: the crucial role of astrocytic mitochondria
Liu, D., Guo, P., Wang, Y., & Li, W. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1516119 · Cited by 8 · see citing works
Burton, J. K., Brothers, H. M., Hutchison, R. M., Murphy, J. M., Sun, T., Dent, G. W., Curiale, G. G., & Kowalski, K. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100202 · Cited by 8 · see citing works
Xie, G., Jiang, G., Huang, L., Sun, S., Wan, Y., Li, F., Wu, B., Zhang, Y., Li, X., Xiong, B., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18060790 · Cited by 10 · see citing works
- Authors
- Fortea, J., Pegueroles, J., Alcolea, D., Belbin, O., Dols-Icardo, O., Vaqué-Alcázar, L., Videla, L., Gispert, J. D., Suárez-Calvet, M., Johnson, S. C., Sperling, R., Bejanin, A., Lleó, A., & Montal, V.
- Affiliations
- Hospital de Sant Pau (ES)
- Universitat Pompeu Fabra (ES)
- University of Wisconsin–Madison (US)
- Brigham and Women's Hospital (US)
- Barcelona Supercomputing Center (ES)
- Corresponding author
- Fortea, Juan
- Montal, Víctor
- ORCID
- Venue
- Nature Medicine
- Published
- 2024-05
- Volume
- 30
- Issue
- 5
- Pages
- 1284-1291
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC13310155
- OpenAlex
- W4396673676
- Cited by
- 369
- References
- 32
- Citations by year
- 2026: 110 · 2025: 191 · 2024: 67 · 2023: 1
- FWCI
- 104.73
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-06-17)
- Open access
- Licence
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Funders
- U.S. Department of Health and Human Services (U54HD090256, P01AG036694 and P50AG005134, R21 AG056974, R01 AG027161, S10 OD025245, UF1AG051216, P50 AG033514, and P30 AG062715, UL1 TR002373, P30 AG062715, R01 AG061566, R01 AG054059, R01 AG037639)
- Alzheimer's Association (AARG-22-923680)
- European Commission (948677 and 847648, H2020-SC1-BHC-2018-2020, Grant 2021)
- Generalitat de Catalunya (SLT006/17/00119, SLT002/16/00408)
- Ministerio de Economía y Competitividad (PI22/00307, PI20/01330, PI20/01473, PI18/00435, PI22/00456)
- Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona (LCF/PR/GN17/50300004)
- National Institutes of Health (5u01ag024904-10, 1s10od025245-01, UL1TR002373)
- National Institute on Aging (U01-AG-024904, R01AG081394, UF1AG051216, RF1AG056850, R61AG066543, R01AG037639, R01AG063689, P50AG033514, RF1AG061566, P50AG005134, R21AG056974, R01AG021155, R01AG027161, U24AG057437, P01AG036694, R01AG054059, P30AG062715, U24AG072122)
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD090256)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- Alzheimer's disease, APOE3, amyloid PET, cerebrospinal fluid amyloid, tau PET, symptom onset age, disease progression, autosomal dominant Alzheimer's disease, Down syndrome, penetrance, dementia stages
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Amyloid, Apolipoproteins E, Female, Homozygote, Humans, Male, Middle Aged, Cohort Studies, Biomarkers, Amyloid beta-Peptides, tau Proteins, Age of Onset, Positron-Emission Tomography, Apolipoprotein E3, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
